Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer.
Metastatic triple-negative breast cancer (TNBC) is a heterogeneous disease with a poor prognosis and currently with few treatment options. Treatment of these patients is highly based on systemic chemotherapy. Some targeted drugs were recently approved for these patients: two poly(ADP-ribose) polymer...
| Published in: | Breast Cancer: Basic & Clinical Research pp. 1 - 15 |
|---|---|
| Main Authors: | , |
| Format: | review tables/charts Journal Article |
| Published: |
Sage Publications Inc.
1/1/2021
|
| Online Access: | View this record in EBSCOhost |